<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Why weight-loss drugs don’t work for some people — Live Feed</title><link>https://www.live-feeds.com/feed/why-weight-loss-drugs-don-t-work-for-some-people</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/why-weight-loss-drugs-don-t-work-for-some-people/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Understanding GLP-1 Weight-Loss Drug Non-Response</title><link>https://www.live-feeds.com/feed/why-weight-loss-drugs-don-t-work-for-some-people</link><guid isPermaLink="false">https://www.live-feeds.com/feed/why-weight-loss-drugs-don-t-work-for-some-people#u6244</guid><pubDate>Sat, 20 Jun 2026 17:55:56 +0000</pubDate><description>GLP-1 receptor agonists like Ozempic and Wegovy generally cause users to lose up to 15% of body fat. However, a significant portion of users do not respond to these medications. Effectiveness varies based on genetics, lifestyle, and medical adherence.What's confirmed:GLP-1 receptor agonists such as Ozempic and Wegovy can lead to an average body fat loss of 15%.These medications were originally created to help patients with type 2 diabetes manage blood sugar.GLP-1 drugs improve insulin sensitivity and stimulate insulin secretion when blood levels are elevated.Still unconfirmed:Between 10% and 3</description></item>
</channel></rss>